CD274 and gastric neoplasm: Besides, dostarlimab-gxly may be used to treat patients with MSI-H/dMMR gastric tumors that have progressed on or after prior treatment, who have no satisfactory alternative treatment options, and who had not previously received a PD-1 or PD-L1 inhibitor.